Education
About Us
Working with TipRanks
Follow Us
Shandong Weigao Group Medical Polymer Co Ltd Class H (HK:1066)
:1066
1066 Stock Chart & Stats
HK$5.55
HK$0.12(2.84%)
At close: 4:00 PM EST
HK$5.55
HK$0.12(2.84%)
Day’s Range― - ―
52-Week RangeHK$4.82 - HK$7.39
Previous CloseN/A
Volume8.70M
Average Volume (3M)10.92M
Market Cap
HK$23.11B
Enterprise ValueHK$16.74B
Total Cash (Recent Filing)HK$9.65B
Total Debt (Recent Filing)HK$5.51B
Price to Earnings (P/E)11.0
Beta1.11
Next Earnings
Mar 31, 2026EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend Yield4.58%
Share Statistics
EPS (TTM)0.25
Shares Outstanding4,522,332,500
10 Day Avg. Volume7,849,305
30 Day Avg. Volume10,915,466
Financial Highlights & Ratios
PEG Ratio2.08
Price to Book (P/B)0.82
Price to Sales (P/S)1.49
P/FCF Ratio8.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$6.70Price Target Upside20.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High ProfitabilitySustained high gross and healthy net margins indicate durable pricing power and efficient cost structure in core polymer medical consumables. This profitability supports internal reinvestment, dividend capacity and resilience to cost shocks over the medium term.
Prudent Balance SheetA conservative leverage profile and strong equity base provide financial flexibility to fund capex, sustain dividends, and absorb cyclical pressure. This reduces refinancing risk and supports strategic investments without materially raising default risk.
Recurring Consumables BusinessA focus on disposable medical polymer consumables creates recurring demand and high customer stickiness from hospitals and clinics. Structural healthcare consumption and repeat usage underpin predictable revenue streams and long-term market stability.
Bears Say
Slight Revenue DeclineA falling top line, even if modest, erodes operating leverage and constrains capacity to expand margins or invest in growth. If sustained, revenue decline could force margin trade-offs or limit the company's ability to scale R&D and commercial efforts over months.
Cash-Flow Visibility GapsMissing operating cash flow figures and unavailable FCF growth reduce clarity on cash conversion and free cash flow sustainability. This opacity hinders assessment of dividend, capex and debt service durability, raising medium-term financing risk.
Limited Public DisclosureAbsence of earnings call disclosure and guidance limits investor insight into strategy, margin drivers and demand trends. Over months this reduces transparency into management execution and complicates assessment of long-term priorities and risk mitigation.
Shandong Weigao Group Medical Polymer Co News
1066 FAQ
What was Shandong Weigao Group Medical Polymer Co Ltd Class H’s price range in the past 12 months?
Shandong Weigao Group Medical Polymer Co Ltd Class H lowest stock price was HK$4.82 and its highest was HK$7.39 in the past 12 months.
What is Shandong Weigao Group Medical Polymer Co Ltd Class H’s market cap?
Shandong Weigao Group Medical Polymer Co Ltd Class H’s market cap is HK$23.11B.
When is Shandong Weigao Group Medical Polymer Co Ltd Class H’s upcoming earnings report date?
Shandong Weigao Group Medical Polymer Co Ltd Class H’s upcoming earnings report date is Mar 31, 2026 which is in 36 days.
How were Shandong Weigao Group Medical Polymer Co Ltd Class H’s earnings last quarter?
Shandong Weigao Group Medical Polymer Co Ltd Class H released its earnings results on Aug 27, 2025. The company reported HK$0.249 earnings per share for the quarter, missing the consensus estimate of HK$0.294 by -HK$0.045.
Is Shandong Weigao Group Medical Polymer Co Ltd Class H overvalued?
According to Wall Street analysts Shandong Weigao Group Medical Polymer Co Ltd Class H’s price is currently Undervalued.
Does Shandong Weigao Group Medical Polymer Co Ltd Class H pay dividends?
Shandong Weigao Group Medical Polymer Co Ltd Class H pays a Notavailable dividend of HK$0.106 which represents an annual dividend yield of 4.58%. See more information on Shandong Weigao Group Medical Polymer Co Ltd Class H dividends here
What is Shandong Weigao Group Medical Polymer Co Ltd Class H’s EPS estimate?
Shandong Weigao Group Medical Polymer Co Ltd Class H’s EPS estimate is 0.23.
How many shares outstanding does Shandong Weigao Group Medical Polymer Co Ltd Class H have?
Shandong Weigao Group Medical Polymer Co Ltd Class H has 4,522,332,500 shares outstanding.
What happened to Shandong Weigao Group Medical Polymer Co Ltd Class H’s price movement after its last earnings report?
Shandong Weigao Group Medical Polymer Co Ltd Class H reported an EPS of HK$0.249 in its last earnings report, missing expectations of HK$0.294. Following the earnings report the stock price went down -4.984%.
Which hedge fund is a major shareholder of Shandong Weigao Group Medical Polymer Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:1066
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shandong Weigao Group Medical Polymer Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.57%
12-Months-Change
Fundamentals
Return on Equity
8.34%
Trailing 12-Months
Asset Growth
6.10%
Trailing 12-Months
Company Description
Shandong Weigao Group Medical Polymer Co Ltd Class H
Shandong Weigao Group Medical Polymer Co., Ltd. is a leading Chinese manufacturer specializing in the production of medical devices and polymer products. Established in 1992, the company operates primarily in the healthcare sector, offering a diverse range of products including intravenous (IV) systems, infusion pumps, and other medical consumables. Weigao is recognized for its commitment to innovation and quality, serving hospitals and healthcare providers both domestically and internationally.
1066 Stock 12 Month Forecast
Average Price Target
HK$6.70
▲(20.72% Upside)
Technical Analysis
―
PW Medtech Group Ltd.
―
Modern Dental Group Limited
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Shanghai Conant Optical Co. Ltd. Class H
―
Options Prices
Currently, No data available
---